Short-Term Plasticity of Gray Matter Associated with Leptin Deficiency and Replacement

Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90024, USA.
The Journal of Clinical Endocrinology and Metabolism (Impact Factor: 6.21). 05/2011; 96(8):E1212-20. DOI: 10.1210/jc.2011-0314
Source: PubMed


Leptin affects neurogenesis, neuronal growth, and viability. We previously reported that leptin supplementation increased gray matter (GM) concentration in the anterior cingulate gyrus (ACG), cerebellum, and inferior parietal lobule, areas that are also involved in food intake.
The aim of this study was to report the changes in brain structure at different states of leptin supplementation.
We conducted a nonrandomized trial.
We studied three adults with congenital leptin deficiency due to a mutation in the leptin gene. Intervention: Patients received treatment with recombinant methionyl human leptin, with annual 11- to 36-d periods of treatment withholding followed by treatment restoration over 3 yr.
GM concentration (by voxel-based morphometry analysis of magnetic resonance scans) was correlated with body mass index (BMI) and leptin supplementation.
Annually withholding leptin supplementation for several weeks increased BMI and reversed the original effects of leptin in the cerebellum and ACG. The changes in the ACG were consistent with an indirect effect of leptin mediated through increased BMI. In the cerebellum, where leptin receptors are most dense, GM changes appeared to be direct effects of leptin. Leptin restoration did not lead to recovery of GM in the short term but did lead to an unexpected GM increase in the posterior half of the left thalamus, particularly the pulvinar nucleus.
These findings provide the first in vivo evidence of remarkably plastic, reversible, and regionally specific effects of leptin on human brain morphology. They suggest that leptin may have therapeutic value in modulating plasticity-dependent brain functions.

Download full-text


Available from: Gilberto Paz-Filho, Feb 20, 2014
  • Source
    • "There is increasing evidence that the cerebellum plays an important role in feeding and eating behaviours, and it might in fact be a 'central node' for regulation of feeding intake, with connections from/to the hypothalamus (Mahler, Guastavino, Jacquart, & Strazielle, 1993; Zhu & Wang, 2008). Posterior cerebellum activation has been shown when showing images of desirable food (Berman et al., 2013), and posterior cerebellum grey matter plasticity has been shown in response to leptin (London et al., 2011). Given that the cerebellum also plays a role in cognitive function, emotion regulation (Schmahmann, 2010), the role of the cerebellum in ED requires further exploration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study investigates the prevalence of eating disorder (ED) psychopathology, neuropsychological function, structural brain correlates and risk mechanisms in a prospective cohort of very preterm (VPT) young adults. We assessed ED psychopathology and neuropsychological correlates in 143 cohort individuals born at <33 weeks of gestation. Structural brain correlates and risk factors at birth, in childhood and adolescence, were investigated using prospectively collected data throughout childhood/adolescence. VPT-born individuals had high levels of ED psychopathology at age 21 years. Executive function did not correlate with ED symptomatology. VPT adults presenting with ED psychopathology had smaller grey matter volume at age 14/15 years in the left posterior cerebellum and smaller white matter volume in the fusiform gyrus bilaterally, compared with VPT adults with no ED psychopathology. Caesarean delivery predicted engaging in compensatory behaviours, and severe eating difficulty at age 14 years predicted ED symptomatology in young adulthood. VPT individuals are at risk for ED symptomatology, with evidence of associated structural alterations in posterior brain regions. Further prospective studies are needed to clarify the pathways that lead from perinatal/obstetric complications to ED and relevant neurobiological mechanisms. © 2015 The Authors. European Eating Disorders Review published by John Wiley &Sons, Ltd.
    European Eating Disorders Review 01/2015; 23(2). DOI:10.1002/erv.2346 · 2.46 Impact Factor
  • Source
    • "The adipocyte-brain crosstalk is mediated to a large extent by adipokines and this circuit plays a pathophysiological role beyond obesity and cardiometabolic conditions (Nakamura et al., 2013; Paz-Filho et al., 2010). Leptin influences neurotransmitters such as dopamine (Ishibashi et al., 2012) and impacts gray matter plasticity (London et al., 2011). Consequently, a putative role for leptin, adiponectin and resistin in the pathophysiology of neuropsychiatric conditions associated with metabolic abnormalities, including MDD has emerged (vide infra) (Diniz et al., 2012; Liu et al., 2012; Lu et al., 2006; Weber-Hamann et al., 2007; Yamada et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adiponectin, leptin and resistin may play a role in the pathophysiology of major depressive disorder (MDD). However, differences in peripheral levels of these hormones are inconsistent across diagnostic and intervention studies. Therefore, we performed meta-analyses of diagnostic studies (i.e., MDD subjects versus healthy controls) and intervention investigations (i.e., pre-vs. post-antidepressant treatment) in MDD. Adiponectin (N = 1278; Hedge's g = -0.35; P = 0.16) and leptin (N = 893; Hedge's g = -0.018; P = 0.93) did not differ across diagnostic studies. Meta-regression analyses revealed that gender and depression severity explained the heterogeneity observed in adiponectin diagnostic studies, while BMI and the difference in BMI between MDD individuals and controls explained the heterogeneity of leptin diagnostic studies. Subgroup analyses revealed that adiponectin peripheral levels were significantly lower in MDD participants compared to controls when assayed with RIA, but not ELISA. Leptin levels were significantly higher in individuals with mild/moderate depression versus controls. Resistin serum levels were lower in MDD individuals compared to healthy controls (N = 298; Hedge's g = -0.25; P = 0.03). Leptin serum levels did not change after antidepressant treatment. However, heterogeneity was significant and sample size was low (N = 108); consequently meta-regression analysis could not be performed. Intervention meta-analyses could not be performed for adiponectin and resistin (i.e., few studies met inclusion criteria). In conclusion, this systematic review and meta-analysis underscored that relevant moderators/confounders (e.g., BMI, depression severity and type of assay) should be controlled for when considering the role of leptin and adiponectin as putative MDD diagnostic biomarkers.
    Journal of Psychiatric Research 08/2014; 59. DOI:10.1016/j.jpsychires.2014.08.002 · 3.96 Impact Factor
  • Source
    • "Similarly, in three congenitally leptin deficient human adults, leptin treatment has been shown to increase gray matter volume in cerebellum, inferior parietal, and anterior cingulate cortices [113]. Furthermore, in these same patients, small reductions in gray matter volume were detected in these same areas when leptin treatment was discontinued [114]. In healthy adults, plasma leptin levels have been associated with total brain volume, independent of body size [115] [116] [117]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Receptors of leptin, the prototypical adipokine, are expressed throughout the cortex and several other areas of the brain. Although typically studied for its role in energy intake and expenditure, leptin plays a critical role in many other neurocognitive processes and interacts with various other hormones and neurotransmitters to perform these functions. Here, we review the literature on how leptin influences brain development, neural degradation, Alzheimer’s disease, psychiatric disorders, and more complicated cognitive functioning and feeding behaviors. We also discuss modulators of leptin and the leptin receptor as they relate to normal cognitive functioning and may mediate some of the actions of leptin in the brain. Although we are beginning to better understand the critical role leptin plays in normal cognitive functioning, there is much to be discovered.
    Metabolism 07/2014; 64(1). DOI:10.1016/j.metabol.2014.07.004 · 3.89 Impact Factor
Show more